|
Getting the Most Innovative Drugs to Market: What Can the FDA Do?
|
|
Tuesday, February 7, 2006
|
 |
| Yet, in recent years there has been a decline in the number of innovative new drugs reaching the market, despite extraordinary advances in the basic and applied science upon which these new |
|
|
Knowledge and the Growth Process
|
|
Thursday, February 2, 2006
|
|
| At this AEI conference, a panel of experts will discuss how knowledge and innovation have been key to new economic growth. |
|
|
Conflict of Interest or Fruitful Collaboration?
|
|
Friday, September 16, 2005
|
|
| Discussion of the National Institutes of Health's new rules that sharply limit outside consulting and other potential conflicts of interest.
|
|
|
The $253 Million Vioxx Verdict
|
|
Wednesday, September 7, 2005
|
|
| On August 19, 2005, a jury in Angleton, Texas, found Vioxx producer Merck liable for the death of fifty-nine-year-old Robert Ernst. |
|
|
Tort Reform
|
|
Thursday, April 21, 2005
|
|
| Anup Malani and Charles H. Mullin present their recent study on liability in asbestos-related lawsuits. |
|
|
The Perils of Re-importation
|
|
Friday, April 15, 2005
|
|
| A panel of experts from AEI examine the repercussions of reimportation for American drug safety and for pharmaceutical innovation. |
|
|
Is There a Crisis in Medical Malpractice?
|
|
Thursday, March 31, 2005
|
|
| This Health Policy Discussion presents a new study of medical malpractice outcomes that argues that settlements are not the main factor driving soaring malpractice premiums. |
|
|
Follow-on Drug Development
|
|
Wednesday, December 15, 2004
|
|
| Panelists discuss the pharmaceutical industry's development of "follow-on" drugs and whether or not consumers benefit from such a practice. |
|
|
Improving Health Care
|
|
Monday, November 8, 2004
|
|
| A discussion of the proper role of competition in health care markets in light of a recent Federal Trade Commission and Department of Justice joint report on improving health care. |
|
|
What Happened to the European Pharmaceutical Industry?
|
|
Thursday, October 7, 2004
|
|
| Professor Fabio Pammolli of the University of Florence describes the nature and causes of the momentous shift in the pharmaceutical market from Europe to America. |
|
|
| Total Records: 47 |
|
